Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Boehler

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|June 20, 2018
D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infectionsPauline Dartevelle, Claire Ehlinger, Abdurraouf Zaet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2011
Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progressionChristian Boehler, Laurent R Gauthier, Oliver Mortusewicz, et al.
Cell Death and Differentiation|November 17, 2018
PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancersCarole Beck, José Manuel Rodriguez-Vargas, Christian Boehler, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Friend, not Foe: Lowered Tissue Reactivity to Long-Term Polyimide ImplantsCorinne Orlemann, Laura M De Santis, Paul Neering, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2026
Friend, Not Foe: Lowered Tissue Reactivity to Long-Term Polyimide ImplantsCorinne Orlemann, Laura M De Santis, Paul Neering, et al.
Scientific Reports|November 11, 2017
D-Cateslytin, a new antimicrobial peptide with therapeutic potentialAbdurraouf Zaet, Pauline Dartevelle, Fadoua Daouad, et al.
Nucleic Acids Research|March 7, 2014
PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathwaysCarole Beck, Christian Boehler, Josée Guirouilh Barbat, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|June 20, 2018
D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infectionsPauline Dartevelle, Claire Ehlinger, Abdurraouf Zaet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2011
Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progressionChristian Boehler, Laurent R Gauthier, Oliver Mortusewicz, et al.
Cell Death and Differentiation|November 17, 2018
PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancersCarole Beck, José Manuel Rodriguez-Vargas, Christian Boehler, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Friend, not Foe: Lowered Tissue Reactivity to Long-Term Polyimide ImplantsCorinne Orlemann, Laura M De Santis, Paul Neering, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2026
Friend, Not Foe: Lowered Tissue Reactivity to Long-Term Polyimide ImplantsCorinne Orlemann, Laura M De Santis, Paul Neering, et al.
Scientific Reports|November 11, 2017
D-Cateslytin, a new antimicrobial peptide with therapeutic potentialAbdurraouf Zaet, Pauline Dartevelle, Fadoua Daouad, et al.
Nucleic Acids Research|March 7, 2014
PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathwaysCarole Beck, Christian Boehler, Josée Guirouilh Barbat, et al.
Pageof 3